139 related articles for article (PubMed ID: 22349253)
1. Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study.
Del Pup L; Postruznik D; Corona G
Maturitas; 2012 May; 72(1):93-4. PubMed ID: 22349253
[TBL] [Abstract][Full Text] [Related]
2. Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
Del Pup L
Gynecol Endocrinol; 2012 Sep; 28(9):740-5. PubMed ID: 22409649
[TBL] [Abstract][Full Text] [Related]
3. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
4. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
5. Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations.
López-Belmonte J; Nieto C; Estevez J; Delgado JL; del Prado JM
Maturitas; 2012 Aug; 72(4):353-8. PubMed ID: 22683083
[TBL] [Abstract][Full Text] [Related]
6. Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets.
Eugster-Hausmann M; Waitzinger J; Lehnick D
Climacteric; 2010 Jun; 13(3):219-27. PubMed ID: 20423242
[TBL] [Abstract][Full Text] [Related]
7. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
8. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
[TBL] [Abstract][Full Text] [Related]
10. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
[TBL] [Abstract][Full Text] [Related]
11. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
12. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: Serum levels and vaginal response including tissue biomarkers associated with tissue remodeling.
Illston JD; Wheeler TL; Parker CR; Conner MG; Burgio KL; Goode PS; Richter HE
Maturitas; 2015 Aug; 81(4):475-9. PubMed ID: 26115591
[TBL] [Abstract][Full Text] [Related]
13. Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment: is it safe even in cancer patients?
Del Pup L; Di Francia R; Cavaliere C; Facchini G; Giorda G; De Paoli P; Berretta M
Anticancer Drugs; 2013 Nov; 24(10):989-98. PubMed ID: 24080714
[TBL] [Abstract][Full Text] [Related]
14. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
Panay N; Maamari R
Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
[TBL] [Abstract][Full Text] [Related]
15. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
[TBL] [Abstract][Full Text] [Related]
16. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
[TBL] [Abstract][Full Text] [Related]
17. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
18. TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol.
Archer DF; Constantine GD; Simon JA; Kushner H; Mayer P; Bernick B; Graham S; Mirkin S;
Menopause; 2017 May; 24(5):510-516. PubMed ID: 28002201
[TBL] [Abstract][Full Text] [Related]
19. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
[No Abstract] [Full Text] [Related]
20. Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem.
Mitchell CM; Srinivasan S; Plantinga A; Wu MC; Reed SD; Guthrie KA; LaCroix AZ; Fiedler T; Munch M; Liu C; Hoffman NG; Blair IA; Newton K; Freeman EW; Joffe H; Cohen L; Fredricks DN
Menopause; 2018 May; 25(5):500-507. PubMed ID: 29206774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
